HOWL
Income statement / Annual
Last year (2023), Werewolf Therapeutics, Inc.'s total revenue was $19.94 M,
an increase of 21.60% from the previous year.
In 2023, Werewolf Therapeutics, Inc.'s net income was -$37.37 M.
See Werewolf Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$19.94 M
|
$16.40 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.76 M |
$2.51 M |
$735,000.00 |
$777,000.00 |
$463,000.00 |
| Gross Profit |
$18.18 M |
$13.89 M |
-$735,000.00 |
-$777,000.00 |
-$463,000.00 |
| Gross Profit Ratio |
0.91 |
0.85 |
0 |
0 |
0 |
| Research and Development
Expenses |
$41.78 M
|
$53.76 M
|
$35.27 M
|
$16.64 M
|
$6.34 M
|
| General & Administrative
Expenses |
$18.67 M
|
$18.70 M
|
$14.82 M
|
$5.76 M
|
$3.60 M
|
| Selling & Marketing
Expenses |
-$1.76 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$16.91 M
|
$18.70 M
|
$14.82 M
|
$5.76 M
|
$3.60 M
|
| Other Expenses |
-$1.14 M |
$2.25 M |
$104,000.00 |
$7.26 M |
$430,000.00 |
| Operating Expenses |
$58.68 M |
$72.46 M |
$50.09 M |
$22.40 M |
$9.94 M |
| Cost And Expenses |
$60.45 M |
$72.46 M |
$50.09 M |
$22.40 M |
$9.94 M |
| Interest Income |
$7.42 M |
$1.91 M |
$104,000.00 |
$101,000.00 |
$372,000.00 |
| Interest Expense |
$3.14 M |
-$1.10 M |
$0.00 |
$0.00 |
$372,000.00 |
| Depreciation &
Amortization |
$1.76 M
|
$2.51 M
|
$735,000.00
|
$777,000.00
|
$463,000.00
|
| EBITDA |
-$38.74 M
|
-$56.06 M
|
-$50.09 M
|
-$22.25 M
|
-$9.54 M
|
| EBITDA Ratio |
-1.94 |
-3.42 |
0 |
0 |
0 |
| Operating Income Ratio
|
-2.03
|
-3.42
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.14 M
|
$2.25 M
|
$104,000.00
|
$7.36 M
|
-$312,000.00
|
| Income Before Tax |
-$37.37 M |
-$53.81 M |
-$49.98 M |
-$15.04 M |
-$10.25 M |
| Income Before Tax Ratio
|
-1.87
|
-3.28
|
0
|
0
|
0
|
| Income Tax Expense |
$1.60 M |
-$2.25 M |
-$216,000.00 |
-$101,000.00 |
$742,000.00 |
| Net Income |
-$37.37 M |
-$51.56 M |
-$49.77 M |
-$14.94 M |
-$10.99 M |
| Net Income Ratio |
-1.87 |
-3.14 |
0 |
0 |
0 |
| EPS |
-1.05 |
-1.79 |
-1.82 |
-0.52 |
-0.38 |
| EPS Diluted |
-1.05 |
-1.79 |
-1.82 |
-0.52 |
-0.38 |
| Weighted Average Shares
Out |
$35.65 M
|
$28.86 M
|
$27.31 M
|
$28.66 M
|
$28.66 M
|
| Weighted Average Shares
Out Diluted |
$35.65 M
|
$28.86 M
|
$27.31 M
|
$28.66 M
|
$28.66 M
|
| Link |
|
|
|
|
|
